The company states: “The consolidated MCR for the second quarter of 2023 was 87.5%, reflecting continued strong operating performance and medical cost management. The Medicaid MCR for the second quarter of 2023 was 88.3%, in line with the Company’s expectation and long-term target range. The Medicare MCR for the second quarter of 2023 was 89.2%, above the Company’s long-term target range, reflecting higher utilization of outpatient and professional services and higher MCRs associated with membership growth.”
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
See Insiders’ Hot Stocks on TipRanks >>
Read More on MOH: